148 related articles for article (PubMed ID: 25069262)
1. [Anti-NMDA receptor antibody in systemic lupus erythematosus].
Gono T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):225-30. PubMed ID: 25069262
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
[TBL] [Abstract][Full Text] [Related]
4. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
5. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
6. Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives.
Steup-Beekman G; Steens S; van Buchem M; Huizinga T
Lupus; 2007; 16(5):329-34. PubMed ID: 17576734
[TBL] [Abstract][Full Text] [Related]
7. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
Hanly JG; Robichaud J; Fisk JD
J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112
[TBL] [Abstract][Full Text] [Related]
8. NR2-reactive antibody decreases cell viability through augmentation of Ca(2+) influx in systemic lupus erythematosus.
Gono T; Takarada T; Fukumori R; Kawaguchi Y; Kaneko H; Hanaoka M; Katsumata Y; Yoneda Y; Yamanaka H
Arthritis Rheum; 2011 Dec; 63(12):3952-9. PubMed ID: 22012858
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
Půtová I; Dostal C; Becvar R
Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
[TBL] [Abstract][Full Text] [Related]
10. Antibodies and the brain: anti-N-methyl-D-aspartate receptor antibody and the clinical effects in patients with systemic lupus erythematosus.
Arinuma Y
Curr Opin Neurol; 2018 Jun; 31(3):294-299. PubMed ID: 29474315
[TBL] [Abstract][Full Text] [Related]
11. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
12. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.
Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A
Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968
[TBL] [Abstract][Full Text] [Related]
13. VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.
van Vollenhoven RF; Bieber MM; Powell MJ; Gupta PK; Bhat NM; Richards KL; Albano SA; Teng NN
J Rheumatol; 1999 Aug; 26(8):1727-33. PubMed ID: 10451069
[TBL] [Abstract][Full Text] [Related]
14. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
15. Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.
Chang EH; Volpe BT; Mackay M; Aranow C; Watson P; Kowal C; Storbeck J; Mattis P; Berlin R; Chen H; Mader S; Huerta TS; Huerta PT; Diamond B
EBioMedicine; 2015 Jul; 2(7):755-64. PubMed ID: 26286205
[TBL] [Abstract][Full Text] [Related]
16. Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case-control study.
Park DJ; Takahashi Y; Kang JH; Yim YR; Kim JE; Lee JW; Lee KE; Lee JK; Lee SS
Clin Exp Rheumatol; 2017; 35 Suppl 105(3):54-60. PubMed ID: 28339361
[TBL] [Abstract][Full Text] [Related]
17. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
18. Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus.
Diamond B; Bloom O; Al Abed Y; Kowal C; Huerta PT; Volpe BT
J Intern Med; 2011 Jan; 269(1):36-44. PubMed ID: 21158976
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody induction by DNA-containing immune complexes requires HMGB1 with the TLR2/microRNA-155 pathway.
Wen Z; Xu L; Chen X; Xu W; Yin Z; Gao X; Xiong S
J Immunol; 2013 Jun; 190(11):5411-22. PubMed ID: 23616573
[TBL] [Abstract][Full Text] [Related]
20. Antinucleosome antibodies correlate with the disease severity in children with systemic lupus erythematosus.
Wu JF; Yang YH; Wang LC; Lee JH; Shen EY; Chiang BL
J Autoimmun; 2006 Sep; 27(2):119-24. PubMed ID: 16919912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
